Tranexamic acid for trauma.

摘要

We were very interested in the CRASH-2 trial. It showed not only the efficacy of tranexamic acid, but also its excellent safety in a large cohort of patients. Although the inclusion criteria for this trial were very relevant to routine clinical practice, hypotension in a trauma patient can be related to other causes (pneumothorax, spinal cord injury, etc) and not necessarily to documented bleeding.